Skip to Main Content

Good morning, fellow humans. Erin Brodwin here, filling in for Ed Silverman. My unofficial mascot, a 25-pound pup named Dax, has fallen asleep to the sound of my typing as I sip away at my usual cup of Bolivian Fair Trade Certified coffee. The only flavored coffee I’ve ever tried is hazelnut, and one taste of that saccharin brew was enough to pull me back to the regular stuff. Here’s hoping your day is neither bitter nor overly sweet. On to the day’s news. …

A U.S. judge in the Purdue Pharma bankruptcy case plans to rule on the company’s request to approve its opioid settlement by week’s end, Reuters reports. The judge, New York-based Robert Drain, said he expected to make a ruling on Friday as to whether to approve Purdue’s request for a settlement related to its sale of opioids. The OxyContin maker claims the deal is worth more than $10 billion and has pledged $4.5 billion in exchange for legal protections against opioid-related lawsuits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment